• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植九年之后发生的迟发性急性抗体介导排斥反应。

Late acute antibody mediated rejection after nine years of renal transplantation.

作者信息

Halim Medhat Abdel, Al-Otaibi Torki, Al-Waheeb Salah, Tawab Khaled Abdel, El Kholy Osama, Nair Prasad, Said Tarek, Narayanan Nampoory M R

机构信息

Hamed Alessa Organ Transplantation Center, Mubarak Al-Kabeer Hospital, Kuwait.

出版信息

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1111-4.

PMID:21060182
Abstract

Acute antibody mediated rejection (AMR) is rarely reported as a long-term com-plication of renal transplantation, and it can present on top of another chronic pathology affecting the graft. A 45-year-old gentleman with chronic kidney disease due to unknown etiology received renal transplantation from his sister with 4 HLA mismatches. He received antithymocte globulin induction therapy and was maintained on steroids, azathioprine (AZA) and cyclosporine A (CsA). Up to eight years post-transplantation he was clinically and biochemically stable. He lost follow-up for about one year, and then presented with nephritic nephrotic syndrome and rise of serum creatinine (SCr.) to 210 μmol/L. Graft biopsy revealed picture suggestive of acute AMR on top of de novo membranoprolipherative glomerulonephritis (MPGN) with focal crescent formation, diffuse immune complex deposition and peritubular capillaries C4d positivity. Anti-HLA donor specific antibodies were highly positive for B and T cells class I and class II. The patient was treated with intravenous immunoglobulin, plasma exchange and anti-CD20 (rituximab). AZA was changed to mycophenolate mofetil and CsA to tacrolimus. He had partial response, but SCr. continued at 220 μmol/L.

摘要

急性抗体介导的排斥反应(AMR)作为肾移植的长期并发症鲜有报道,且它可能出现在影响移植肾的另一种慢性病变之上。一名45岁病因不明的慢性肾脏病男性患者接受了来自其妹妹的肾移植,有4个HLA错配。他接受了抗胸腺细胞球蛋白诱导治疗,并维持使用类固醇、硫唑嘌呤(AZA)和环孢素A(CsA)。移植后长达八年,他在临床和生化方面都保持稳定。他失访了约一年,随后出现肾炎性肾病综合征,血清肌酐(SCr)升至210μmol/L。移植肾活检显示,在新发膜增生性肾小球肾炎(MPGN)伴局灶性新月体形成、弥漫性免疫复合物沉积和肾小管周围毛细血管C4d阳性的基础上,有提示急性AMR的表现。抗HLA供体特异性抗体对I类和II类B细胞和T细胞呈高度阳性。该患者接受了静脉注射免疫球蛋白、血浆置换和抗CD20(利妥昔单抗)治疗。AZA换成了霉酚酸酯,CsA换成了他克莫司。他有部分反应,但SCr仍维持在220μmol/L。

相似文献

1
Late acute antibody mediated rejection after nine years of renal transplantation.肾移植九年之后发生的迟发性急性抗体介导排斥反应。
Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1111-4.
2
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.使用抗胸腺细胞球蛋白(ATG)单药治疗以及利妥昔单抗、静脉注射免疫球蛋白和血浆置换联合治疗活检证实的急性抗体介导排斥反应:从初步经验中获得的教训
Clin Transpl. 2014:223-30.
3
[Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].[在接受尸体肾移植的超敏患者中联合使用免疫球蛋白、血浆置换和利妥昔单抗进行诱导治疗]
Nefrologia. 2010;30(2):252-7. doi: 10.3265/Nefrologia.pre2010.Jan.10233. Epub 2010 Jan 22.
4
Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.在移植前存在供体特异性抗体阳性和 CDC 交叉配型阴性的情况下,肾移植后 1 年内频繁发生亚临床慢性抗体介导的排斥反应。
Hum Immunol. 2013 Sep;74(9):1111-8. doi: 10.1016/j.humimm.2013.06.022. Epub 2013 Jun 18.
5
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.在慢性排斥反应的肾移植受者中,使用他克莫司和霉酚酸酯控制抗供体抗体产生
Transplantation. 2001 Jul 15;72(1):77-83. doi: 10.1097/00007890-200107150-00016.
6
Highly Sensitized Patients: Miami Transplant Institute Experience.高敏患者:迈阿密移植研究所的经验
Clin Transpl. 2014:171-8.
7
Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.通过抗CD20治疗和移植期血液分离术实现的具有供体特异性HLA抗体患者的活体供肾移植。
Atheroscler Suppl. 2013 Jan;14(1):199-202. doi: 10.1016/j.atherosclerosissup.2012.10.030.
8
Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.全淋巴照射、低剂量静脉注射免疫球蛋白和抗胸腺细胞球蛋白联合作为高敏和抗体介导排斥反应肾移植受者的挽救治疗
Clin Transpl. 2014:215-21.
9
Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.高度HLA致敏患者活体肾移植前的脱敏治疗:一项单中心研究
Transplant Proc. 2015 Oct;47(8):2332-5. doi: 10.1016/j.transproceed.2015.09.025.
10
Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.霉酚酸酯对肾移植中供者特异性抗体形成的影响。
Clin Transplant. 2005 Apr;19(2):168-74. doi: 10.1111/j.1399-0012.2005.00261.x.